Oct 12▲ MACD Positive CrossoverHistogram +0.0316, positive momentum
Oct 10▲ MACD Positive CrossoverHistogram +0.0316, positive momentum
About BlackRock Capital Allocation Term Trust
As a financial services company, BlackRock Capital Allocation Term Trust (BCAT) competes in the Asset Management space. The company carries a $1.40B market cap, placing it firmly in the small-cap category.
Premium feature
News & analytics is part of Premium.
Every headline for this ticker with a sentiment reading, refreshed daily.
Per-headline sentiment, scored by a finance-tuned model
See exactly where the price sits versus its 150-day moving average, the live RSI reading, MACD momentum, and volume context, for any ticker, every day.
Where BCAT stands vs its 150-day and 200-day moving averages
As of the October 12, 2026 close, BCAT finished 5.12% below its 150-day moving average ($14.46) and 2.42% below its 200-day moving average ($14.06). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is BCAT overbought or oversold?
At the October 12, 2026 close, BCAT's RSI(14) was 36.0, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Key stats
Market Cap$1.40B
P/E (TTM)5.49
EPS$2.40
52W Change-9.9%
Dividend Yield22.77%
Analysis
Investors considering BlackRock Capital Allocation Term Trust should weigh the typical risks associated with BCAT's sector, size, and financial profile against their own risk tolerance and investment objectives. No single metric tells the full story. Reviewing BCAT's risk profile alongside its fundamentals and technical indicators provides a more complete picture.
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms